An interventional study of JJVC Investigational Multifocal Contact Lens TEST Lens and ACUVUE® OASYS Multifocal in Visual Acuity, sponsored by Johnson & Johnson Vision Care, Inc.. Completed at 1 site in United States. Open to participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-06.
Sponsored by Johnson & Johnson Vision Care, Inc. · Not applicable, Interventional, and Treatment
This is a single-masked, bilateral, controlled, randomized, 2x2 crossover, non-dispensing clinical trial to characterize the effects of an HEV-Blocker on several measures of visual function in a presbyopic population.
Johnson & Johnson Vision Care, Inc. is the lead sponsor of 220 studies on the registry; 2 are open to participants now.
Of its 110 completed or terminated interventional studies of FDA-regulated products, 101 (92%) have results posted.
Counted across the registry records on this site, refreshed daily.
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
Exclusion Criteria:
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
Eligible subjects will be randomly assigned to contact lens wear sequence TEST/CONTROL in a bilateral fashion.
Device: JJVC Investigational Multifocal Contact Lens TEST Lens · Device: ACUVUE® OASYS Multifocal
Eligible subjects will be randomly assigned to contact lens wear sequence CONTROL/ TEST in a bilateral fashion.
Device: JJVC Investigational Multifocal Contact Lens TEST Lens · Device: ACUVUE® OASYS Multifocal
TEST Lens
CONTROL Lens
Starburst Diameter (mm)
The starburst diameter (mm) was measured each subject binocularly. Starburst diameter was quantified by the horizontal spread of the spokes emerging from the center of a small, point-like stimulus. A calibrated custom-made micrometer (two sides with reverse threading) was used to spread two posts out from a central mid-point. The posts attach to a custom-designed ruler that indicates the lateral spread of the starburst. Measurements for this metric are positive. Smaller diameter indicates better lens performance. The average diameter (mm) for each lens type was reported by period.
Time frame: 30-minutes post lens insertion
Halos Diameter (mm)
Halo diameter (mm) was quantified and measured using the same micrometer as for starbursts diameter (mm). The Halo diameter (mm) was measured each subject binocularly. Measurements for halo diameter are positive, where smaller values indicate better performance. The average diameter (mm) for each lens type.
Time frame: 30-minutes post lens insertion
Glare Disability Threshold
Glare disability threshold was collected binocularly for each subject. Subjects were exposed to a target stimulus for 2 seconds; before the measurement was taken the annulus was set to a level below that which would cause the target stimulus to be veiled. The experimenter would then adjust the intensity of the annulus until subjects could no longer see the target stimulus. Subjects would indicate this by pressing a buzzer. Glare disability thresholds take on positive values, where higher values indicate better lens performance. The average glare disability level (change in log relative energy) for each lens type was reported.
Time frame: 30-minutes post lens insertion
Glare Discomfort (mm)
The Glare discomfort was evaluated by calculating the change in height of the palpebral fissure measured while the participant views the mid-wave central grating target, compared to the maximal squint during a 5-second Photostress exposure induced by a solid, 10-degree broadband field, which completely obscures the target (\~10-deg diameter). Both eyes were recorded and averaged, to produce an average palpebral fissure height before and during the Photostress exposure. Glare discomfort can take on negative and positive values, where smaller values indicate better lens performance. The average glare discomfort (change in palpebral fissure height) for each lens type was reported.
Time frame: 30-minutes post lens insertion
Heterochromatic Contrast Threshold (HCT)
Using the same optical bench set-up described Glare Disability Threshold, to measure HCT, participants viewed the mid-wave (580 nm) grating target presented on presented on a short wave (460 nm) "sky-light background." The intensity of the background was adjusted, until the participant was no longer able to resolve the grating target. The log relative energy of the background needed to obscure the central target was recorded as HCT. Heterochromatic contrast thresholds are positive values, where higher values indicate better lens performance. The average threshold each lens type was reported.
Time frame: 30-minutes post lens insertion
Two-Point Threshold (mm) With 403nm Filter
To create the two-point threshold stimulus, a single point- source like stimulus was spread into two distinct points of light, using a custom-built, collapsible light baffle. The two-point threshold was quantified as the minimum distance (mm) at which a participant could detect two distinct points of light, separated by a small black space. Measurements for this metric are positive. Smaller distances indicate better lens performance. The average distance for each lens type and period.
Time frame: 30-minutes post lens insertion
Two-Point Threshold (mm) Without 403nm Filter
To create the two-point threshold stimulus, a single point- source like stimulus was spread into two distinct points of light, using a custom-built, collapsible light baffle. The two-point threshold was quantified as the minimum distance (mm) at which a participant could detect two distinct points of light, separated by a small black space. Measurements for this metric are positive. Smaller distances indicate better lens performance. The average distance for each lens type.
Time frame: 30-minutes post lens insertion
A total of 37 subjects were enrolled into this study. Of those enrolled, 35 were fit into at least 1 study lens, while 2 subjects failed to meet all eligibility criteria. Of those dispensed, 25 subjects completed the study, while 10 subjects were discontinued.
| Milestone | Senofilcon A\Senofilcon A (C3) | Senofilcon A (C3)\ Senofilcon A |
|---|---|---|
| Started | 17 | 18 |
| Completed | 12 | 13 |
| Not completed | 5 | 5 |
| Withdrew: Covid-19 related | 1 | 0 |
| Withdrew: Withdrawal by subject | 0 | 1 |
| Withdrew: Subject discontinued due to timing | 4 | 4 |
| Milestone | Senofilcon A\Senofilcon A (C3) | Senofilcon A (C3)\ Senofilcon A |
|---|---|---|
| Started | 12 | 13 |
| Completed | 12 | 13 |
| Not completed | 0 | 0 |
The starburst diameter (mm) was measured each subject binocularly. Starburst diameter was quantified by the horizontal spread of the spokes emerging from the center of a small, point-like stimulus. A calibrated custom-made micrometer (two sides with reverse threading) was used to spread two posts out from a central mid-point. The posts attach to a custom-designed ruler that indicates the lateral spread of the starburst. Measurements for this metric are positive. Smaller diameter indicates better lens performance. The average diameter (mm) for each lens type was reported by period.
| mm | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Period 1 | 77.06 ± 25.900 | 64.13 ± 27.703 |
| Period 2 | 67.26 ± 30.991 | 54.24 ± 22.706 |
Halo diameter (mm) was quantified and measured using the same micrometer as for starbursts diameter (mm). The Halo diameter (mm) was measured each subject binocularly. Measurements for halo diameter are positive, where smaller values indicate better performance. The average diameter (mm) for each lens type.
| mm | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Halos Diameter (mm) | 69.24 ± 19.033 | 52.93 ± 17.725 |
Glare disability threshold was collected binocularly for each subject. Subjects were exposed to a target stimulus for 2 seconds; before the measurement was taken the annulus was set to a level below that which would cause the target stimulus to be veiled. The experimenter would then adjust the intensity of the annulus until subjects could no longer see the target stimulus. Subjects would indicate this by pressing a buzzer. Glare disability thresholds take on positive values, where higher values indicate better lens performance. The average glare disability level (change in log relative energy) for each lens type was reported.
| log (change in log relative energy) | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Glare Disability Threshold | 2.62 ± 0.235 | 2.86 ± 0.179 |
The Glare discomfort was evaluated by calculating the change in height of the palpebral fissure measured while the participant views the mid-wave central grating target, compared to the maximal squint during a 5-second Photostress exposure induced by a solid, 10-degree broadband field, which completely obscures the target (\~10-deg diameter). Both eyes were recorded and averaged, to produce an average palpebral fissure height before and during the Photostress exposure. Glare discomfort can take on negative and positive values, where smaller values indicate better lens performance. The average glare discomfort (change in palpebral fissure height) for each lens type was reported.
| mm | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Glare Discomfort (mm) | 9.88 ± 4.164 | 6.61 ± 3.151 |
Using the same optical bench set-up described Glare Disability Threshold, to measure HCT, participants viewed the mid-wave (580 nm) grating target presented on presented on a short wave (460 nm) "sky-light background." The intensity of the background was adjusted, until the participant was no longer able to resolve the grating target. The log relative energy of the background needed to obscure the central target was recorded as HCT. Heterochromatic contrast thresholds are positive values, where higher values indicate better lens performance. The average threshold each lens type was reported.
| log (change in log relative energy) | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Heterochromatic Contrast Threshold (HCT) | 1.85 ± 0.221 | 2.14 ± 0.295 |
To create the two-point threshold stimulus, a single point- source like stimulus was spread into two distinct points of light, using a custom-built, collapsible light baffle. The two-point threshold was quantified as the minimum distance (mm) at which a participant could detect two distinct points of light, separated by a small black space. Measurements for this metric are positive. Smaller distances indicate better lens performance. The average distance for each lens type and period.
| mm | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Period 1 | 16.49 ± 5.600 | 7.51 ± 2.889 |
| Period 2 | 13.21 ± 5.021 | 9.50 ± 6.321 |
To create the two-point threshold stimulus, a single point- source like stimulus was spread into two distinct points of light, using a custom-built, collapsible light baffle. The two-point threshold was quantified as the minimum distance (mm) at which a participant could detect two distinct points of light, separated by a small black space. Measurements for this metric are positive. Smaller distances indicate better lens performance. The average distance for each lens type.
| mm | Senofilcon A | Senofilcon A (C3) |
|---|---|---|
| Two-Point Threshold (mm) Without 403nm Filter | 8.63 ± 3.391 | 5.47 ± 1.953 |
Collected over Throughout the duration of the study; approximately 5- 10 days per subject.. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Senofilcon A (C3) | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Senofilcon A | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
All subjects fitted at least one study lens.
| Age, Continuous(Years) | Fitted Subjects |
|---|---|
| Mean | 51.8 ± 7.95 |
| Sex: Female, Male(Participants) | Fitted Subjects |
|---|---|
| Female | 30 |
| Male | 5 |
| Race/Ethnicity, Customized(Participants) | Fitted Subjects |
|---|---|
| Black or African American | 6 |
| White | 29 |
| Region of Enrollment(Participants) | Fitted Subjects |
|---|---|
| United States | 35 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Johnson \& Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johnson & Johnson Vision Care, Inc.